Globus Medical (GMED) Gains from Investment Securities (2016 - 2026)

Globus Medical (GMED) has 11 years of Gains from Investment Securities data on file, last reported at $6.4 million in Q1 2026.

• Quarterly Gains from Investment Securities rose 3703.59% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (down 26.83% YoY) and the FY2025 annual result came in at $13.5 million, down 49.24% from the prior year.
• Gains from Investment Securities slipped to $6.4 million in Q1 2026, from $10.8 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $17.9 million in Q4 2024 to a low of -$4.1 million in Q3 2024.
• A 5-year average of $4.1 million and a median of $1.2 million in 2023 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2024 — Gains from Investment Securities sank 458.91% — and 2026, when it soared 3703.59%.
• Tracing GMED's Gains from Investment Securities over 5 years: stood at $7.2 million in 2022, then soared by 81.23% to $13.0 million in 2023, then soared by 37.76% to $17.9 million in 2024, then sank by 39.74% to $10.8 million in 2025, then sank by 41.15% to $6.4 million in 2026.
• The last three Gains from Investment Securities figures came in at $6.4 million (Q1 2026), $10.8 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.